中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝细胞癌诊断标志物的研究进展

任一彬 王红阳

引用本文:
Citation:

肝细胞癌诊断标志物的研究进展

详细信息
  • 中图分类号: R735.7

The progress of diagnostic marker in hepatocellular carcinoma

  • [1]Bosch FX, Ribes J.Primary liver cancer:Worldwide incidence andtrends[J].Gastroenterology, 2004, 127 (15) ∶S5-S16.
    [2]Srivatanakul P, Sriplung H, Deerasamee S.Epidemiology of livercancer:an overview[J].Asian Pac J Cancer Prev, 2004, 5 (2) ∶118-125.
    [3]Yao DF, Dong ZZ, Yao M.Specific molecular markers in hepato-cellular carcinoma[J].Hepatobiliary Pancreat Dis Int, 2007, 6 (3) ∶241-247.
    [4]Pei Y, Zhang T, Ranault V, et al.An overview of hepatocellularcarcinoma study by omics-based methods[J].Acta Biochim Bio-phys Sin, 2009, 41 (1) ∶1.
    [5]Llovet JM, Ricci S, Mazzaferro V, et al.Sorafenib in AdvancedHepatocellular Carcinoma[J].N Engl J Med, 2008, 359 (4) ∶378-390.
    [6]Zhou L, Liu J, Luo F.Serum tumor markers for detection of hepa-tocellular carcinoma[J].World J Gastroenterol, 2006, 12 (8) ∶1175-1181.
    [7]Gupta S, Bent S, Kohlwes J.Test characteristics of alpha-fetopro-tein for detecting hepatocellular carcinoma in patients with hepatitisC.A systematic review and critical analysis[J].Ann Intern Med, 2003, 139 (1) ∶46-50.
    [8]Soresi M, Magliarisi C, Campagna P, et al.Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma[J].Anti-cancer Res, 2003, 23∶1747-1753.
    [9]Grizzi F, Franceschini B, Hamrick C, et al.Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment ofhepatocellular carcinoma[J].J Transl Med, 2007, 5∶3.
    [10]Li D, Mallory T, Satomura S.AFP-L3:a newgeneration of tumormarker for hepatocellular carcinoma[J].Clin Chim Acta, 2001, 313 (1-2) ∶15-19.
    [11]Llovet JM, Chen Y, Wu rmbach E, et al.AMolecular Signature toDiscriminate Dysplastic Nodules From Early Hepatocellular Carcino-ma in HCV Cirrhosis[J].Gastroenterology, 2006, 131 (6) ∶1758-1767.
    [12]Man XB, Wang HY.Upregulation of Glypican-3 expression inhepatocellular carcinoma but downregulation in cholangiocarcinomaindicates its differential diagnosis value in primary livercancers[J].Liver International, 2005, 25 (5) ∶962-966.
    [13]Capurro M, Wanless IR, Sherman M, et al.Glypican-3:a novelserum and histochemical marker for hepatocellular carcinoma[J].Gastroenterology, 2003, 125 (1) ∶89-97.
    [14]Hippo Y, Watanabe K, Watanabe A, et al.Identification of solubleNH2-terminal fragment of glypican-3 as a serological marker forearly-stage hepatocellular carcinoma[J].Cancer Res, 2004, 64 (7) ∶2418-2423.
    [15]Di Tommaso L, Destro A, seok JY, et al.The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection ofhepatocellular carcinoma[J].J Hepatology, 2009, 50 (4) ∶746-754.
    [16]Liebman HA, Furie BC, Tong MJ, et al.Des-gamma-carboxyprothrombin as a serum marker of primary hepatocellularcarcinoma[J].N Engl J Med, 1984, 310 (22) ∶1427-1431.
    [17]Volk ML, Hernandez JC, et al.Risk factors for hepatocellular carcino-ma may impair the performance of biomarkers:a comparison of AFP, DCP, and AFP-L3[J].Cancer Biomark, 2007, 3∶79-87.
    [18]Kladney RD, Bulla GA, Guo L, et al.A novel Golgi-localizedprotein upregulated by viral infection[J].Gene, 2000, 249 (1-2) ∶53-65.
    [19]Spanggenberg HC, Thimme R, Blum HE.Serum Markers of Hepa-tocellular Carcinoma[J].Seminars In Liver Disease, 2006, 26 (4) ∶385-390.
    [20]Dawson S, Higashitsaji H, Wilkinson AJ, et al.Gankyrin:a newoncoprotein and regulator of pRb and p53[J].Trends in Cell Biolo-gy, 2006, 16 (5) ∶229-233.
    [21]Fu X, Tan L, Liu S, et al.A novel diagnostic marker, p28GANKdistinguishes hepatocellular carcinoma from potential mimics[J].JCancer Res Clin Oncol, 2004, 130 (9) ∶514-520.
    [22]Fu XY, Wang HY, Tan L, et al.Overexpression of p28/gankyrinin human hepatocellular carcinoma and its clinical significance[J].World J Gastroenterol, 2002, 8 (4) ∶638-643.
    [23]Li H, Fux, Chen Y, et al.Use of Adenovirus-Delivered siRNAtoTarget Oncoprotein p28GANK in Hepatocellular Carcinoma[J].Gastroenterology, 2005, 128 (7) ∶2029-2041.
    [24]Qiu W, Wu J, Walsh EM, et al.Retinoblastoma protein modulatesgankyrin-MDM2 in regulation of p53 stability and chemosensitivityin cancer cells[J].Oncogene, 2008, 27 (29) ∶4034-4043.
    [25]Tan L, Fu XY, Liu SQ, et al.Expression of p28GANKand its cor-relation with RB in human hepatocellular carcinoma[J].Liver In-ternational, 2005, 25 (3) ∶667-676.
    [26]Chen Y, Li HH, Fu J, et al.Oncoprotein p28GANKbinds to RelAand retains NF-κB in the cytoplasm through nuclear export[J].Cell Research, 2007, 17 (12) ∶1020-1029.
  • 加载中
计量
  • 文章访问数:  3364
  • HTML全文浏览量:  7
  • PDF下载量:  904
  • 被引次数: 0
出版历程
  • 出版日期:  2010-04-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回